Indian pharmaceutical market registers over 8% growth in June 2024
GSK's antibiotic drug Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands for June 2024, with sales of Rs 76 crore and Rs 66 crore, respectively